Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

ease visit www.mgipharma.com or www.dacogen.com for full prescribing information.

About Gliadel(R) Wafer

Gliadel is a biodegradable wafer containing the chemotherapy agent carmustine, or BCNU, and is indicated in newly diagnosed patients with high-grade malignant glioma as an adjunct to surgery and radiation.

Gliadel is also indicated in recurrent glioblastoma multiforme patients as an adjunct to surgery. As a Gliadel Wafer dissolves, BCNU is delivered directly to the site once occupied by the tumor. Side effects that have been reported in patients receiving Gliadel include seizures, intracranial infections, abnormal wound healing, and brain edema (swelling). Although these events may result as a consequence of brain surgery (craniotomy) without Gliadel, they may occur more frequently when Gliadel is used. In clinical studies, the most common side effects that occurred more often in patients receiving Gliadel than in patients receiving placebo, included pain and abnormal wound healing. Please visit www.gliadel.com for full prescribing information.

About MGI PHARMA

MGI PHARMA, INC. is a biopharmaceutical company focused in oncology and acute care that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(R) (decitabine) for Injection and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. MGI PHARMA directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information, please visit www.mgipharma.com.

This news release contains certain "forward-looking" statements within the meaning of the P
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/6/2009)...,, - Trial Will Compare NXL103 With Leading...esistant Staphylococcus Aureus (MRSA) Infections ,...pany focused on the discovery and,development of n...ant global,problem of microbial resistance, announ...l NXL103 (flopristin/linopristin), has started a P...
(Date:11/5/2009)...ea Technologies, Inc., a leading provider of devel...tical products announced the addition of customize...m of services, which will be overseen by the newly...tion Development. This investment in an experience...long with new laboratory facilities and state-of-t...
(Date:11/5/2009)...stCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" ...trial of Topical Interferon Alpha-2b for the treat...ent enrollment, with the required 120th patient ra...d and placebo-controlled Phase II trial is underwa...ents participating in the trial self-administer ac...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 1Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 1BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 2BMEYE B V Completes EUR 6 Million Series B Financing Round 5329 3Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 1Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 2Advanced Health Media Announces Acquisition of Ephikacy LLC 5324 3
...d YONGIN, South Korea, Jan. 12 Jennerex,Inc. (San... Korean partner,Green Cross Corp., today announced... primary liver cancer clinical trial using its tar...xicities were reported, and enrollment of,patients...rial involves treatment of patients with advanced,...
... 12 Cara Therapeutics, Inc. today announced that ...long-acting peripheral kappa opioid agonist, CR845...-controlled trial will be conducted in the United ...d safety of intravenous CR845 during the post-oper...ted hysterectomy. The trial is expected to enroll ...
Other Medicine Technology:Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 2Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 3Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer 4Cara Therapeutics Initiates Phase II Proof-Of-Concept Trial of Novel Analgesic in Acute Post-Operative Pain 2
(Date:11/8/2009)...Passage of Health Care Reform Bill ,, Critica...overage for all Americans ,, CHICAGO, Nov. 7 /... House of Representatives passed by a vote of 220-...would strengthen Medicare for seniors and end disc...ions of Americans out of affordable health coverag...
(Date:11/7/2009)...PRNewswire-USNewswire/ -- Karen Ignagni, President...), released the following statement today on House...y support comprehensive health care reform, and we...a complete overhaul of how health insurance is pro...overage, elimination of pre-existing condition exc...
(Date:11/7/2009)...n (CT), David A. Cook (GA), Louis J. Goodman (TX),...d ,, CHICAGO, Nov. 7 /PRNewswire-USNewswire/ -...sented five medical society executive leaders with...o the goals and ideals of the medical profession. ... policy making meeting in Houston. ,, (Logo: ...
(Date:11/7/2009)...atholics have a responsibility to vigorously oppos... quo." ,, WASHINGTON, Nov. 7 /PRNewswire-US... Brown released the following statement on the new... Nancy Pelosi,s Affordable Health Care for America... the status quo for abortion is voted upon. ,,...
(Date:11/7/2009)...lic Relations Society of America (PRSA) will besto...Lofgren, senior vice president of Brand Strategy, ...ht at a ceremony at PRSA,s 2009 International Conf... PRSA College of Fellows is one of the profession,... APR, SAGE, Fellow PRSA, and 2009 chair of the Col...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
...h Inc. announced today,that it will independently ...ies to outside firms in the pharmaceutical and bio...ue its 23-year collaboration with Pfizer but,will ...d dispersion (SDD) technology,(which increases the...
...y reduces risk of chronic diseases and,can help re...nation, CHICAGO, Oct. 20 Small steps can lead to...lthier Life Steps campaign,launched today. As fami...lthy lifestyle at little or no cost. New,resources...
... less effective, more painful than singular proced...-- Laser therapies to remove unwanted hair may be ...er than in combination, according to an Iranian st...r long-pulsed 755-nanometer alexandrite lasers (12...
...on Plan(TM), Health Management Program to ... U.S. Preventive Medicine(R), the leader,in diseas...fers,Association (AGA Tour), a Lilburn, GA -based .... The Prevention,Plan(TM) is a groundbreaking heal...
...tCall/ - The Westaim Corporation,announced today i...ting,obligations associated with its previous Nasd....S. Securities and Exchange Act of 1934, as,amende...hares will continue to trade on the TSX under the ...
...caling Back Chronic Disease,Initiatives, WASHINGT...sponding to reports that many Americans are forgoi...day called for renewed vigilance,in the fight agai... or carpooling, for example -- we can,t afford to,...
Other Medicine News:Health News:Bend Research Offers Broad Access to Drug-Delivery Solutions 2Health News:AMA Aims to Help Americans Get Healthier One Step at a Time 2Health News:Study Evaluates Laser Therapies for Hair Removal 2Health News:U.S. Preventive Medicine(R) Tees Up with Amateur Golf Association 2Health News:Westaim to deregister its common stock in the United States 2Health News:Nation's Economic Downturn Threatens Continuity of Care for Chronic Conditions 2
27 Gauge Air Injection Cannula
Reverse Double Barreled Irrigation/Aspiration Set
Irrigation/Aspiration Cannula
Infusion Lens Loop
Medicine Products: